Famciclovir: Review of clinical efficacy and safety

Antiviral Research

Volumn 29, Issue 2-3, 1996, Pages 141-151

  Cirelli, Richard ^a   Herne, Kathleen ^a   McCrary, Monica ^a   Lee, Patricia ^a   Tyring, Stephen K ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

clinical efficacy, famciclovir; famciclovir; herpes simplex, clinical studies; safety testing, famciclovir; varicella zoster, clinical studies

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; FAMCICLOVIR; PENCICLOVIR; PENCICLOVIR TRIPHOSPHATE; PLACEBO; VIRUS DNA;

ADULT; AGED; ANTIVIRAL ACTIVITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; FEMALE; GENITAL HERPES; HEADACHE; HEPATITIS B; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES ZOSTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PHOSPHORYLATION; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; REINFECTION; REVIEW; SKIN DEFECT; VARICELLA ZOSTER VIRUS;

HEPATITIS B VIRUS; HERPES; HERPES ZOSTER; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 3;

EID: 0030007902     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-3542(95)00941-8     Document Type: Short Survey

References (54)

1. Angus, P., Richards, M., Bowden, S., Ireton, J., Jones, R. and Locarnini, S. Successful treatment of post liver transplant recurrent hepatitis B. Presented at 34th Interscience Conf. Antimicrobial Agents and Chemotherapy, Oct. 1994, Orlando, FL, USA.
2. Angus, P., Neuhaus, P., Manns, M.P. and the Famciclovir Liver Transplant Group. An open study to assess the effect of famciclovir on hepatitis B replication in patients who have received an orthotopic liver transplant. Presented at Liver Transplantation for Chronic Viral Hepatitis, Mar. 1995. Reston, VA, USA.
3. Bacon, T. and Schinazi, R. (1993) An overview of the further evaluation of penciclovir against herpes simplex virus and varicella-zoster virus in cell culture, highlighting contrasts with acyclovir. Antiviral Chem. Chemother. 4 (Suppl. 1), 25-36.
4. Bebault, G.M., Wall, R.A., Rennie, B.A. and Sacke, S.L. (1995) Penciclovir (PCV) triphosphate (PCVTP) and acyclovir (ACV) triphosphate (ACVTP) in a human schwannoma continuous cell line (SW) infected with varicella zoster virus (VZV). Can. J. Infect. Dis. 6, 287c.
5. Boike, S., Pue, M., Audet, P.R., et al. (1994) Pharmacokinetics of famciclovir in subjects with chronic hepatic disease. J. Clin. Pharmacol. 34, 1199-1207.
6. Boker, K.H.W., Ringe, B., Froger, M., Picelmayr, R. and Manns, M.P. (1994) Prostaglandin E plus famciclovir - a new concept for the treatment of severe hepatitis B after liver transplantation. Transplantation 57, 1706-1708.
7. Boyd, M.R., Bacon, T.H., Sutton, D. and Cole, M. (1987) Antiherpesvirus activity of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) in cell culture. Antimicrob. Agents Chemother. 31, 1238-1242.
8. Boyd, M.R., Boon, R.J., Fowles, S.E., et al. (1988) Some biological properties of BRL 42810, a well-absorbed oral prodrug of the anti-herpesvirus agent BRL 39123. Antiviral Res. 9, 146.
9. Boyd, M.R., Safrin, S. and Kern, E.R. (1993) Penciclovir: a review of spectrum of activity, selectivity, and cross-resistance pattern. Antiviral Chem. Chemother. 4 (Suppl. 1), 3-11.
10. Chiou, H.C., Kumura, K., Hu, A., Kerns, K.M. and Coen, D.M. (1995) Penciclovir-resistance mutations in the herpes simplex virus DNA polymerase gene. Antiviral Chem. Chemother. 6(5), 281-288.
11. Corey, L. (1994) The current trend in genital herpes. Progress in prevention. Sex. Transm. Dis. 21 (Suppl. 2), 38-44.
12. Degreef, H. and the Famciclovir Herpes Zoster Clinical Study Group. (1994) Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients. Int. J. Antimicrob. Agents 4, 241-246.
13. de Miranda, P. and Good, S.S. (1992) Species differences in the metabolism and disposition of antiviral nucleoside analogues: 1. Acyclovir. Antiviral Chem. Chemother. 3, 1-8.
14. de Moragas, J.M. and Kierland, R.R. (1957) The outcome of patients with herpes zoster. Arch. Dermatol. 75, 193-196.
15. Earnshaw, D.L., Bacon, T.H., Darlison, S.J., Edmunds, K., Perkins, R.M. and Vere Hodge, R.A. (1992) Mode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex type 1 (HSV-1), HSV-2, and varicella-zoster virus. Antimicrob. Agents Chemother. 36, 2747-2757.
16. Field, H.F., Tewari, D., Sutton, D. and Thackray, A.M. (1995) Comparison of efficacies of famciclovir and valaciclovir against herpes simplex virus type 1 in a murine immunosuppression model. Antimicrob. Agents Chemother. 39, 1114-1119.
17. Hope-Simpson, R.E. (1965) The nature of herpes zoster: a long-term study and a new hypothesis. Proc. R. Soc. Med. 58, 9-20.
18. Huff, J.B., Bean, B., Balfour, H.H., et al. (1988) Therapy of herpes zoster with oral acyclovir. Am. J. Med. 85 (Suppl. 2A), 84-89.
19. Ilsley, D.D., Lee, S.H., Miller, W.H. and Kuchta, R.D. (1995) Acyclic guanosine analogs inhibit DNA polymerases a, b and e with very different potencies and have unique mechanisms of action. Biochemistry 34, 2504-2510.
20. Korba, B. and Boyd, M.R. (1996) Peniciclouir is a selective inhibitor of hepatitis B virus replication in cultured human heptoblastoma cells. Antimicrob. Agents Chemother. (in press).
21. Loeser, J.D. (1986) Herpes zoster and postherpetic neuralgia. Pain 25, 149-164.
22. Main, J., Brown, J.L., Karayiannis, P., et al. (1994) A double-blind, placebo-controlled study to assess the effect of famciclovir on virus replication in patients with chronic hepatitis B infection. J. Hepatol. 21 (Suppl. 1), S32.
23. McKendrick, M.W., McGill, J.I., White, J.E. and Wood, M.J. (1986) Oral acyclovir in acute herpes zoster. Br. Med. J. 293, 1529-1532.
24. Mertz, G.J., Loveless, M.O., Kraus, S.J., Tyring, S.K., Fowler, S.L. and the Collaborative Famciclovir Genital Herpes Research Group. Famciclovir for suppression of recurrent genital herpes. Presented at 34th Interscience Conf. Antimicrobial Agents and Chemotherapy, Oct. 1994, Orlando, FL, USA.
25. Mok, S.S., Shaw, T. and Locarnini, S. Preferential inhibition of human hepatitis B virus (HBV) DNA polymerase by the (R)-enantiomer of penciclovir triphosphate. Presented at 34th Interscience Conf. Antimicrobial Agents and Chemotherapy, Oct. 1995, San Francisco, CA.
26. Mutchnick, M.G., Ehrinpreis, M.N., Kinzie, J.L. and Peleman, R.R. (1994) Prospectives on the treatment of chronic hepatitis B and chronic hepatitis C with thymic peptides and antiviral agents. Antiviral Res. 24, 245-257.
27. Portenoy, R.K., Duma, C. and Foley, K.M. (1986) Acute herpetic and postherpetic neuralgia: clinical review and current management. Ann. Neurol. 20, 651-664.
28. Pue, M.A., Pratt, S.K., Fairless, A.J., et al. (1994) Linear pharmacokinetics of penciclovir following oral administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers. J. Antimicrobiol. Chemother. 33, 119-127.
29. Sacks S.L. (1993) Famciclovir in the treatment of genital herpes infection. Presented at 3rd Congr. European Academy of Dermatology and Venereology, 1993, Copenhagen, Denmark.
30. Sacks, S.L., Aoki, F.Y., Diaz-Mitoma, F. and the Canadian Cooperative Study Group. (1994a) Patient-initiated treatment (Tx) of recurrent genital herpes (RGH) with oral famciclovir (FCV): a Canadian, multicenter, placebo (PLB)-controlled, dose-ranging study. Presented at 34th Interscience Conf. Antimicrobial Agents and Chemotherapy, Oct. 1994, Orlando, FL, USA.
31. Sacks, S.L., Martel, A., Aoki, F., Shafran, S., St-Pierre, C. and Lassondo, M. (1994b) Clinic-initiated treatment of recurrent genital herpes using famciclovir: results of a Canadian, multicenter study. Presented at the Int. Conf. Infectious Diseases, Apr. 1994, Prague, Czechoslovakia.
32. Safrin, S. and Phan, L. (1993) In vitro activity of penciclovir against clinical isolates of acyclovir-resistant and foscarnet-resistant Herpes simplex virus. Antimicrob. Agents Chemother. 37, 2241-2243.
33. Saltzman, R., Jurewicz, R. and Boon, R. (1994) Safety of famciclovir in patients with herpes zoster and genital herpes. Antimicrob. Agents Chemother. 38, 2454-2457.
34. Sasadeusz J.J. and Sacks, S.L. (1993) Systemic antivirals in herpesvirus infections. Derm. Clin. 11, 171-185.
35. Shaw, T., Amor, P., Civitico, G., Boyd, M. and Locarnini, S. (1994) In vitro activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virus. Antimicrob. Agents Chemother. 38(4), 719-723.
36. Standring-Cox, R., Bacon, T.H., Howard, B., Gilbart, J. and Boyd, M.R. (1994) Prolonged activity of penciclovir in cell culture against varicella-zoster virus. Antiviral Res. 23 (Suppl. 1), 96.
37. Straus, S.E. (1993) Shingles: sorrows, salves, and solutions. JAMA 269, 1836-1839.
38. Tallerico, C.L., Phelps, W. and Biron, K.K. (1993) Analysis of the thymidine kinase genes from acyclovir-resistant mutants of varicella-zoster virus isolates from patients with AIDS. J Virol. 67, 1024-1033.
39. Tsiquaye, K.N., Slomka, M.J. and Maung, M. (1994) Famciclovir against duck hepatitis B virus replication in hepatic and nonhepatic tissues of ducklings infected in ovo. J. Med. Virol. 42(3), 306-310.
40. Tyring, S., Barbarash, R.A., Nahlik, J.E., Cunningham, A., Marley, J., Heng, M., Jones, T., Rea, T., Boon, R., Saltzman, R. and the Collaborative Famciclovir Herpes Zoster Study Group (1995) Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. Ann. Intern. Med. 123(2), 89-96.
41. Vere Hodge, R.A. (1993) Famciclovir and penciclovir. The mode of action of famciclovir including its conversion to penciclovir. Antiviral Chem. Chemother. 4(2), 67-84.
42. Vere Hodge, R.A. and Perkins, R.M. (1989) Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-l-yl)guanine (BRL 39123) against herpes simplex virus in MRC-5 cells. Antimicrob. Agents Chemother. 33, 223-229.
43. Vere Hodge, R.A. and Cheng, Y.-C. (1993) The mode of action of penciclovir. Antiviral Chem. Chemother. 4 (Suppl. 1), 13-24.
44. Vere Hodge, R.A., Sutton, D., Boyd, M., Harnden, M.R. and Jarvest, R.L. (1989) Selection of an oral prodrug (BRL 42810; famciclovir) for the antiherpesvirus agent BRL 39123 [9-(4-hydroxy-3-hydroxymethylbut-1-yl)guanine; penciclovir]. Antimicrob. Agents Chemother. 33, 1765-1773.
45. 13C NMR to determine the specificity and absolute configuration of penciclovir phosphate esters formed in HSV-1 and HSV-2-infected cells and by HSV-1-encoded thymidine kinase. Chirality 5, 583-588.
46. 13C NMR to identify the chiral monoacetylated intermediates in the conversion of famciclovir to penciclovir by human intestinal wall extract. Chirality 5, 577-582.
47. Watson, P.N. and Evans, R.J. (1986) Postherpetic neuralgia: a review. Arch. Neurol. 43, 836-840.
48. Weller, S., Blum, R., Doucette, M., et al. (1993) Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single and multiple-dose administration to normal volunteers. Clin. Pharmacol. Ther. 54, 595-605.
49. Whitley, R.J. (1994) Varicella-zoster virus infections. In: K.J. Isselbacher, E. Braunwald, J.D. Wilson, J.B. Martin, A.S. Fauci and D.L. Kasper (Eds), Harrison's Principles of Internal Medicine (13th edition), pp. 787-790. McGrawHill, New York.
50. Wood, M.J., McKendrick, M.W. and McGill, J.I. (1987) Oral acyclovir for acute herpes zoster infections in immune-competent adults. Infection 15 (Suppl. 1), S9-S13.
51. Wood, M.J., Ogan, P.H., McKendrick, M.W., Care, C.D., McGill, J.I. and Webb, E.M. (1988) Efficacy of oral acyclovir treatment of acute herpes zoster. Am. J. Med. 85 (Suppl. 2A), 79-83.
52. Wood, M.J., Johnson, R.W., McKendrick, M.W., Taylor, J., Mandai, B.K. and Crooks, J. (1994) A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. New Engl. J. Med. 330, 896-900.
53. Zoulim F. and Seeger C. (1994) Reverse transcription in Hepatitis B virus is primed by a tyrosine residue of the polymerase. J. Virol. 68, 6-13.
54. Zoulim, F., Dannaoui, C. and Trepo, C. Inhibitory effect of penciclovir on the priming of hepadnavirus reverse transcription. Presented at 54th Interscience Conf. Antimicrobial Agents and Chemotherapy, Oct. 1995, San Francisco, CA.